Search Results

You searched for : MultipleSclerosis

	ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel ... Nov 03
	Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg It is a sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS).... Jun 24
	European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis The approval confirms Aubagio as the first oral multiple sclerosis (MS) therapy for first-line treatment of children and adolescents with MS in the European ... Jun 19
	FDA Authorizes Marketing of Device That Can Improve Gait in Multiple Sclerosis Patients FDA is taking an initiative to authorize the marketing of Portable Neuromodulation Stimulator (PoNS) for Multiple Sclerosis patients which can help patients with their motor ... Apr 15
	USFDA approves Rocheâ€™s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis Shorter infusion time will further improve the twice-yearly treatment experience for OCREVUS, the only B-cell therapy for relapsing and primary progressive MS with ... Dec 15
	Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules After Dr Reddy's, Lupin Ltd. also launches Dimethyl Fumarate Delayed-Release Capsules... Oct 06
	Cipla receives final approval for generic version of Biogen IDEC Inc.â€™s Tecfidera Cipla Limited today announced that it has received final approval for its ANDA for Dimethyl Fumarate Capsules... Sep 25
	Zydus Cadila receives final approval for Dimethyl Fumarate Capsules Dimethyl Fumarate Capsules are indicated for the treatment of multiple sclerosis... Sep 25
8 Matching result(s) found!

-Advertisements-

Trending Now
	Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
	National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
	Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
	Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
	Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
	Akshay Tritiya Parna Mahotsav heldMay 16, 2024
	IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
	Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
	India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
	The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
	Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
	AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024
	Kamineni Doctors Successfully Remove Bone Stuck Near Heart in Elderly PatientMay 14, 2024
	On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology NursesMay 14, 2024
	Shiprocket announces Shiprocket Growth Academy to upskill 100,000 Indian MSMEs through eCommerce learningMay 14, 2024
	5 baby essential gifts for new and expecting momsMay 13, 2024
	BLUM India launches its first State-of-the-Art Experience Centre in HyderabadMay 13, 2024
	Cipla Eyes Eli Lilly Partnership to Tap Growing Demand for Obesity Drugs in IndiaMay 13, 2024
	Setback for Organ Transplantion: First Human to Receive Pig Kidney DiesMay 13, 2024
	Why AstraZeneca is Withdrawing the Covid-19 Vaccine Globally: Explained May 13, 2024

Search Results

ANI Pharmaceuticals announces FDA approval of purified Cortrophin Gel

Zydus Cadila receives tentative approval from USFDA for Fingolimod Capsules .25mg

European Commission approves Aubagio (teriflunomide) as the first oral MS therapy for first-line treatment of children and adolescents living with relapsing-remitting multiple sclerosis

FDA Authorizes Marketing of Device That Can Improve Gait in Multiple Sclerosis Patients

USFDA approves Rocheâ€™s OCREVUS shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis

Lupin Receives Approval for Dimethyl Fumarate Delayed-Release Capsules

Cipla receives final approval for generic version of Biogen IDEC Inc.â€™s Tecfidera

Zydus Cadila receives final approval for Dimethyl Fumarate Capsules

Trending Now